NO20053133L - Kjemiske forbindelser. - Google Patents
Kjemiske forbindelser.Info
- Publication number
- NO20053133L NO20053133L NO20053133A NO20053133A NO20053133L NO 20053133 L NO20053133 L NO 20053133L NO 20053133 A NO20053133 A NO 20053133A NO 20053133 A NO20053133 A NO 20053133A NO 20053133 L NO20053133 L NO 20053133L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- optionally substituted
- independently selected
- chemical connections
- tebazolyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0227704A GB0227704D0 (en) | 2002-11-28 | 2002-11-28 | Chemical compounds |
| GB0310828A GB0310828D0 (en) | 2003-05-10 | 2003-05-10 | Chemical compounds |
| PCT/GB2003/005091 WO2004048350A2 (en) | 2002-11-28 | 2003-11-24 | Oxazolidinones as antibacterial agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20053133D0 NO20053133D0 (no) | 2005-06-27 |
| NO20053133L true NO20053133L (no) | 2005-07-15 |
Family
ID=32395888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20053133A NO20053133L (no) | 2002-11-28 | 2005-06-27 | Kjemiske forbindelser. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7498350B2 (ar) |
| EP (1) | EP1581524A2 (ar) |
| JP (1) | JP2006515601A (ar) |
| KR (1) | KR20050084010A (ar) |
| AU (1) | AU2003285509A1 (ar) |
| BR (1) | BR0316690A (ar) |
| CA (1) | CA2507628A1 (ar) |
| MX (1) | MXPA05005522A (ar) |
| NO (1) | NO20053133L (ar) |
| SA (1) | SA04250095A (ar) |
| TW (1) | TW200533667A (ar) |
| WO (1) | WO2004048350A2 (ar) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ535591A (en) | 2002-02-28 | 2006-07-28 | Astrazeneca Ab | Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| WO2003072575A1 (en) | 2002-02-28 | 2003-09-04 | Astrazeneca Ab | 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents |
| JP4607107B2 (ja) | 2003-07-02 | 2011-01-05 | メルク・シャープ・エンド・ドーム・コーポレイション | シクロプロピル基置換されたオキサゾリジノン抗生物質およびこれらの誘導体 |
| KR100854211B1 (ko) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
| CA2567929A1 (en) * | 2004-05-25 | 2005-12-08 | Astrazeneca Ab | 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents |
| US20090018123A1 (en) * | 2005-06-20 | 2009-01-15 | Milind D Sindkhedkar | Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation |
| US8288416B2 (en) | 2006-09-25 | 2012-10-16 | Wockhardt Ltd. | Substituted piperidinophenyl oxazolidinones |
| WO2008069619A1 (en) * | 2006-12-08 | 2008-06-12 | Legochem Bioscience Ltd. | Novel oxazolidinone derivatives, process for preparing thereof and pharmaceutical composition containing the same |
| JP5236246B2 (ja) * | 2007-10-18 | 2013-07-17 | 株式会社クラレ | スルホニルハライド誘導体の製造方法 |
| JP5352387B2 (ja) * | 2008-09-02 | 2013-11-27 | 株式会社クラレ | スルトン誘導体の製造方法 |
| AU2009303301B2 (en) | 2008-10-10 | 2014-09-11 | Merck Sharp & Dohme Llc | Methods for preparing oxazolidinones and compositions containing them |
| KR20170040371A (ko) | 2009-02-03 | 2017-04-12 | 머크 샤프 앤드 돔 코포레이션 | Ｒ)-3-(4-(2-(2-메틸테트라졸-5-일)피리딘-5-일)-3-플루오로페닐)-5-히드록시메틸 옥사졸리딘-2-온 디히드로겐 포스페이트의 결정형 |
| US8580767B2 (en) | 2009-05-28 | 2013-11-12 | Trius Therapeutics, Inc. | Oxazolidinone containing dimer compounds, compositions and methods to make and use |
| KR101128029B1 (ko) | 2010-03-08 | 2012-03-29 | 주식회사 레고켐 바이오사이언스 | (ｒ)-3-(3-플루오로-4-(1-메틸-5,6-다이하이드로-1,2,4-트리아진-4(1ｈ)-일)페닐)-5-(치환된 메틸)옥사졸리딘-2-온 유도체의 제조방법 |
| FR2975990B1 (fr) * | 2011-06-01 | 2013-05-24 | Rhodia Operations | Procede de preparation d'un compose organique fluore |
| TW201524956A (zh) | 2013-11-12 | 2015-07-01 | Dow Agrosciences Llc | 用於氟化化合物之過程（二） |
| TW201609651A (zh) | 2013-11-12 | 2016-03-16 | 陶氏農業科學公司 | 用於氟化化合物之過程（一） |
| TW201609652A (zh) | 2013-11-12 | 2016-03-16 | 陶氏農業科學公司 | 用於氟化化合物之過程（三） |
| KR101561964B1 (ko) | 2013-11-15 | 2015-10-20 | 한국과학기술연구원 | 옥사졸리디논 화합물 및 이를 포함하는 c형 간염 예방 또는 치료용 약학 조성물 |
| WO2016061772A1 (en) | 2014-10-22 | 2016-04-28 | Merck Sharp & Dohme Corp. | Nargenicin compounds and uses thereof as antibacterial agents |
| TWI726900B (zh) | 2015-08-04 | 2021-05-11 | 美商陶氏農業科學公司 | 用於氟化化合物之過程 |
| KR101855334B1 (ko) * | 2015-12-11 | 2018-06-08 | 에스티팜 주식회사 | 옥사졸리디논 유도체의 중간체 제조방법 |
| EP3723758A4 (en) | 2017-12-13 | 2021-06-23 | Merck Sharp & Dohme Corp. | PHARMACEUTICAL COMPOSITIONS OF TEDIZOLID PHOSPHATE |
| WO2019173548A1 (en) * | 2018-03-07 | 2019-09-12 | Cyclerion Therapeutics, Inc. | Process for preparing soluble guanylate cyclase stimulators |
| CA3183397A1 (en) | 2020-06-18 | 2021-12-23 | Daryl C. Drummond | Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| HUP0301562A2 (hu) * | 2000-06-05 | 2003-12-29 | Dong A Pharm. Co., Ltd. | Új oxazolidinonszármazékok és eljárás ezek előállítására, ezeket tartalmazó gyógyszerkészítmények |
| US20020115669A1 (en) * | 2000-08-31 | 2002-08-22 | Wiedeman Paul E. | Oxazolidinone chemotherapeutic agents |
| ATE332299T1 (de) | 2001-04-07 | 2006-07-15 | Astrazeneca Ab | Eine sulfonimid-gruppe enthaltende oxazolidinone als antibiotika |
| BR0212458A (pt) * | 2001-09-11 | 2004-10-19 | Astrazeneca Ab | Composto ou sal farmaceuticamente aceitável, ou um éster hidrolizável in vivo deste, pró-droga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto ou sal farmaceuticamente aceitável, ou um éster hidrolizável in vivo deste, composição farmacêutica, e, processo para a preparação de um composto ou sais farmaceuticamente aceitável, ou ésteres hidrolizáveis in vivo deste |
| ATE323087T1 (de) * | 2001-10-25 | 2006-04-15 | Aryl substituierte oxazolidinone mit antibacterieller activität | |
| NZ535591A (en) * | 2002-02-28 | 2006-07-28 | Astrazeneca Ab | Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| WO2003072575A1 (en) | 2002-02-28 | 2003-09-04 | Astrazeneca Ab | 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents |
| GB0227701D0 (en) | 2002-11-28 | 2003-01-08 | Astrazeneca Ab | Chemical compounds |
| AU2003302404B2 (en) | 2002-11-28 | 2008-06-19 | Astrazeneca Ab | Oxazolidinone and / or isoxazoline derivatives as antibacterial agents |
-
2003
- 2003-11-24 JP JP2005510254A patent/JP2006515601A/ja active Pending
- 2003-11-24 CA CA002507628A patent/CA2507628A1/en not_active Abandoned
- 2003-11-24 WO PCT/GB2003/005091 patent/WO2004048350A2/en active Application Filing
- 2003-11-24 US US10/536,687 patent/US7498350B2/en not_active Expired - Fee Related
- 2003-11-24 EP EP03778506A patent/EP1581524A2/en not_active Withdrawn
- 2003-11-24 BR BR0316690-2A patent/BR0316690A/pt not_active IP Right Cessation
- 2003-11-24 KR KR1020057009626A patent/KR20050084010A/ko not_active Application Discontinuation
- 2003-11-24 AU AU2003285509A patent/AU2003285509A1/en not_active Abandoned
- 2003-11-24 MX MXPA05005522A patent/MXPA05005522A/es unknown
-
2004
- 2004-04-01 TW TW093109104A patent/TW200533667A/zh unknown
- 2004-04-28 SA SA04250095A patent/SA04250095A/ar unknown
-
2005
- 2005-06-27 NO NO20053133A patent/NO20053133L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05005522A (es) | 2005-07-25 |
| BR0316690A (pt) | 2005-10-18 |
| NO20053133D0 (no) | 2005-06-27 |
| EP1581524A2 (en) | 2005-10-05 |
| TW200533667A (en) | 2005-10-16 |
| CA2507628A1 (en) | 2004-06-10 |
| WO2004048350A2 (en) | 2004-06-10 |
| US20060116386A1 (en) | 2006-06-01 |
| WO2004048350A3 (en) | 2004-10-21 |
| JP2006515601A (ja) | 2006-06-01 |
| AU2003285509A1 (en) | 2004-06-18 |
| KR20050084010A (ko) | 2005-08-26 |
| SA04250095A (ar) | 2005-12-03 |
| US7498350B2 (en) | 2009-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20053133L (no) | Kjemiske forbindelser. | |
| NO20052534L (no) | Oksazolidinon- og/eller isokazolinderivater som antibakterielle stoffer | |
| NO20062269L (no) | Pyridin-karboksylsyrederivater som glucokinasemodulatorer | |
| NO2015020I2 (no) | Ceritinib eller et farmasøytisk akseptabelt salt derav | |
| NO20070032L (no) | Hetroarylbenzamid-derivater for anvendelse som GLK-aktivatorer ved behandling av diabetes | |
| DK0958296T3 (da) | Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme | |
| NO20066055L (no) | Pyridinderivater | |
| NO20063446L (no) | Tiazolderivater | |
| NO20062491L (no) | Benzoksazinderivter og deres anvendelse | |
| NO20073926L (no) | Pyrazolforbindelser som modulerer aktivitet av CDK-, GSK- og aurorakinaser | |
| NO20073960L (no) | Pyrazolderivater for inhibering av CDK og GSK | |
| ATE241617T1 (de) | Pyrimidinverbindungen | |
| NO20052038L (no) | Ny adeninforbindelse og anvendelse derav | |
| ATE253545T1 (de) | Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren | |
| TW200640900A (en) | 1-(2h)-isoquinolone derivative | |
| NO20050666L (no) | 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer | |
| MY139887A (en) | Tetrahydronaphthyridine derivatives and a process for preparing the same. | |
| CY1106358T1 (el) | Νεοι δικυκλικοι αναστολεις της ορμονοευαισθητης λιπασης | |
| NO20072753L (no) | 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer | |
| NO20070157L (no) | Substituerte diketopiperaziner som oksytocinantagonister | |
| NO20080110L (no) | Benzimidazolderivativer som 5-HT6,5-HT24 | |
| NO20063111L (no) | Fremgangsmate for fremstilling av tiazolpyrimidiner | |
| NO20043951L (no) | 3-cyklyl-5-(nitrogenholdig 5-leddet ring) metyl-oksazolidinon-derivater og deres anvendelse som antibakterielle midler | |
| NO20022123L (no) | Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII | |
| TW200510361A (en) | Process of preparating 3-acylaminobenzofuran-2-carboxylic acid derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |